Patent ID: 8409586

Claim:
A liquid formulation comprising human growth hormone; L-lysine or L-arginine; and poly(oxyethylene) poly(oxypropylene) copolymer 188, polyethylene glycol-15 polyoxystearate or polyethylene glycol-35 castor oil, wherein the human growth hormone is present in an amount ranging from 2.5 to 5.5 mg/ml; the L-lysine or L-arginine in an amount ranging from 0.02 to 0.5% (w/v) per mg of the human growth hormone; and the poly(oxyethylene) poly(oxypropylene) copolymer 188, polyethylene glycol-15 polyoxystearate or polyethylene glycol-35 castor oil in an amount ranging from 0.1 to 0.5% (w/v).